Sputum matrix metalloproteases: Comparison between chronic obstructive pulmonary disease and asthma

Respiratory Medicine

Volumn 99, Issue 6, 2005, Pages 703-710

  Culpitt, S V ^a   Rogers, D F ^a   Traves, S L ^a   Barnes, P J ^a   Donnelly, L E ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Elastase; MMP; Neutrophil; TIMP; Tissue inhibitors of metalloprotease

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE MARKER; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; SPUTUM EXAMINATION; ZYMOGRAPHY;

ADULT; ASTHMA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SPUTUM; STATISTICS, NONPARAMETRIC; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 18244396326     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2004.10.022     Document Type: Article

References (41)

1. P.J. Barnes The role of inflammation and anti-inflammatory medication in asthma Respir Med 96 Suppl. A 2002 S9-15
2. S.I. Rennard Inflammation and repair processes in chronic obstructive pulmonary disease Am J Respir Crit Care Med 160 1999 S12-S16
3. E.R. Sutherland R.J. Martin Airway inflammation in chronic obstructive pulmonary disease: Comparisons with asthma J Allergy Clin Immunol 112 2003 819-827
4. National Heart Lung and Blood Institute World Health Organisation. Global initiative for chronic obstructive lung disease, 2001;2701.
5. P.D. Scanlon J.E. Connett L.A. Waller M.D. Altose W.C. Bailey A.S. Buist Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study Am J Respir Crit Care Med 161 2000 381-390
6. S.V. Culpitt D.F. Rogers Evaluation of current pharmacotherapy of chronic obstructive pulmonary disease Expert Opin Pharmacother 1 2000 1007-1020
7. P.J. Barnes New concepts in chronic obstructive pulmonary disease Annu Rev Med 54 2003 113-129
8. J.A. Nadel Role of neutrophil elastase in hypersecretion during COPD exacerbations, and proposed therapies Chest 117 2000 386S-389S
9. S.D. Shapiro Proteinases in chronic obstructive pulmonary disease Biochem Soc Trans 30 2002 98-102
10. National Institutes of Health. Global initiative for asthma: Pocket guide for asthma management and prevention, 2002.
11. J.A. Nadel K. Takeyama C. Agusti Role of neutrophil elastase in hypersecretion in asthma Eur Respir J 13 1999 190-196
12. G. Chiappara R. Gagliardo A. Siena M.R. Bonsignore J. Bousquet G. Bonsignore A.M. Vignola Airway remodelling in the pathogenesis of asthma Curr Opin Allergy Clin Immunol 1 2001 85-93
13. H. Ohbayashi Matrix metalloproteinases in lung diseases Curr Protein Pept Sci 3 2002 409-421
14. L.E. Donnelly D.F. Rogers Antiproteases and retinoids for treatment of COPD Expert Opin Ther Patents 13 2003 1345-1372
15. E.A. Kelly N.N. Jarjour Role of matrix metalloproteinases in asthma Curr Opin Pulm Med 9 2003 28-33
16. W.C. Parks S.D. Shapiro Matrix metalloproteinases in lung biology Respir Res 2 2001 10-19
17. R. Rajah R.V. Nachajon M.H. Collins H. Hakonarson M.M. Grunstein P. Cohen Elevated levels of the IGF-binding protein protease MMP-1 in asthmatic airway smooth muscle Am J Respir Cell Mol Biol 20 1999 199-208
18. K. Prikk P. Maisi E. Pirila M.A. Reintam T. Salo T. Sorsa R. Sepper Airway obstruction correlates with collagenase-2 (MMP-8) expression and activation in bronchial asthma Lab Invest 82 2002 1535-1545
19. K. Imai S.S. Dalal E.S. Chen R. Downey L.L. Schulman M. Ginsburg J. D'Armiento Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema Am J Respir Crit Care Med 163 2001 786-791
20. T. Betsuyaku M. Nishimura K. Takeyabu M. Tanino P. Venge S. Xu Y. Kawakami Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema Am J Respir Crit Care Med 159 1999 1985-1991
21. P. Maisi K. Prikk R. Sepper E. Pirila T. Salo J. Hietanen T. Sorsa Soluble membrane-type 1 matrix metalloproteinase (MT1-MMP) and gelatinase A (MMP-2) in induced sputum and bronchoalveolar lavage fluid of human bronchial asthma and bronchiectasis APMIS 110 2002 771-782
22. R. Suzuki T. Kato Y. Miyazaki M. Iwata Y. Noda K. Takagi N. Nakashima K. Torii Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in sputum from patients with bronchial asthma J Asthma 38 2001 477-484
23. G.A. Finlay K.J. Russell K.J. McMahon E.M. D'Arcy J.B. Masterson M.X. FitzGerald C.M. O'Connor Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients Thorax 52 1997 502-506
24. B. Dahlen J. Shute P. Howarth Immunohistochemical localisation of the matrix metalloproteinases MMP-3 and MMP-9 within the airways in asthma Thorax 54 1999 590-596
25. H. Tanaka N. Miyazaki K. Oashi S. Tanaka M. Ohmichi S. Abe Sputum matrix metalloproteinase-9: Tissue inhibitor of metalloproteinase-1 ratio in acute asthma J Allergy Clin Immunol 105 2000 900-905
26. K.M. Beeh J. Beier O. Kornmann R. Buhl Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects Respir Med 97 2003 634-639
27. M. Hoshino M. Takahashi Y. Takai J. Sim Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma J Allergy Clin Immunol 104 1999 356-363
28. S.V. Culpitt C. De Matos R.E. Russell L.E. Donnelly D.F. Rogers P.J. Barnes Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in chronic obstructive pulmonary disease Am J Respir Crit Care Med 165 2002 1371-1376
29. R.E. Russell S.V. Culpitt C. DeMatos L. Donnelly M. Smith J. Wiggins P.J. Barnes Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease Am J Respir Cell Mol Biol 26 2002 602-609
30. K. Imai S.S. Dalal E.S. Chen R. Downey L.L. Schulman M. Ginsburg J. D'Armiento Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema Am J Respir Crit Care Med 163 2001 786-791
31. K. Ohnishi M. Takagi Y. Kurokawa S. Satomi Y.T. Konttinen Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema Lab Invest 78 1998 1077-1087
32. D. Cataldo C. Munaut A. Noel F. Frankenne P. Bartsch J.M. Foidart R. Louis MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease Int Arch Allergy Immunol 123 2000 259-267
33. K. Brew D. Dinakarpandian H. Nagase Tissue inhibitors of metalloproteinases: Evolution, structure and function Biochim Biophys Acta 1477 2000 267-283
34. W. Mattos S. Lim R. Russell A. Jatakanon K.F. Chung P.J. Barnes Matrix metalloproteinase-9 expression in asthma: Effect of asthma severity, allergen challenge, and inhaled corticosteroids Chest 122 2002 1543-1552
35. A.M. Vignola L. Riccobono A. Mirabella M. Profita P. Chanez V. Bellia G. Mautino P. D'accardi J. Bousquet G. Bonsignore Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis Am J Respir Crit Care Med 158 1998 1945-1950
36. S.E. Wenzel S. Balzar M. Cundall H.W. Chu Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: Association with asthma severity, neutrophilic inflammation, and wound repair J Allergy Clin Immunol 111 2003 1345-1352
37. A. Jatakanon C. Uasuf W. Maziak S. Lim K.F. Chung P.J. Barnes Neutrophilic inflammation in severe persistent asthma Am J Respir Crit Care Med 160 1999 1532-1539
38. J.V. Fahy K.W. Kim J. Liu H.A. Boushey Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation J Allergy Clin Immunol 95 1995 843-852
39. D.D. Cataldo J. Bettiol A. Noel P. Bartsch J.M. Foidart R. Louis Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge Chest 122 2002 1553-1559
40. L. Joos J.Q. He M.B. Shepherdson J.E. Connett N.R. Anthonisen P.D. Pare A.J. Sandford The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function Hum Mol Genet 11 2002 569-576
41. E.A. Kelly W.W. Busse N.N. Jarjour Increased matrix metalloproteinase-9 in the airway after allergen challenge Am J Respir Crit Care Med 162 2000 1157-1161